Consumers and health professionals are advised that SFI Australasia, in consultation with the TGA, has initiated a recall for one batch of Ellura capsules due to the presence of ethylene oxide.
Ellura is a listed medicine used to support urinary tract health.
The affected batch number is:
- N0121301 (expiry 01/2024)
and it was first sold into the Australian market on 1 July 2021.
SFI Australasia is writing to all pharmacies and wholesalers who have purchased this product, advising to inspect stock immediately and quarantine units from the affected batch. All unsold units of the affected batch will be removed from the market.
What should I do?
If you or someone you care for is taking Ellura capsules, check the batch number displayed on the box.
If the box is from the affected batch, stop using the product and return it to the place of purchase for a refund.
